Supplementary Figure 3 from Novel Phosphoinositide 3-Kinase/mTOR Dual Inhibitor, NVP-BGT226, Displays Potent Growth-Inhibitory Activity against Human Head and Neck Cancer Cells In Vitro and In Vivo

Authors:
  • KCKwang-Yu Chang
    Kwang-Yu Chang
  • STShan-Yin Tsai
    Shan-Yin Tsai
  • CWChing-Ming Wu
    Ching-Ming Wu
  • CYChia-Jui Yen
    Chia-Jui Yen
  • BCBin-Fay Chuang
    Bin-Fay Chuang
  • JCJang-Yang Chang
    Jang-Yang Chang

Abstract
PDF file - 515KB, Body weight change of the mice model. The body weight was recorded before treatment for the baseline, and throughout the period of experiment. The plots represent the curve of (A) the dose-dependent BGT226 study, and (B) the comparison study of individual PI3K and mTOR inhibitors.